Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases.
about
Mammalian Krüppel-like factors in health and diseasesThe Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblastsFlow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92aCigarette smoke extract profoundly suppresses TNFα-mediated proinflammatory gene expression through upregulation of ATF3 in human coronary artery endothelial cellsMinnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung CancerT-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organsUbiquitin-dependent degradation of HDAC4, a new regulator of random cell motility.Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells.Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc.Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-Like Factor 4 promoter in vitro and in vivo.Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOSFatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growthIntegration of flow-dependent endothelial phenotypes by Kruppel-like factor 2The shear stress-induced transcription factor KLF2 affects dynamics and angiopoietin-2 content of Weibel-Palade bodies.Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes.MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators.Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium.MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cellsThe myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shockEndothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsNF-κB addiction and its role in cancer: 'one size does not fit all'.Receptor-independent protein kinase C alpha (PKCalpha) signaling by calpain-generated free catalytic domains induces HDAC5 nuclear export and regulates cardiac transcription."Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress.Transcription factor MEF2C suppresses endothelial cell inflammation via regulation of NF-κB and KLF2Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis.Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.NF-κB and hypoxia: a double-edged sword in atherosclerosisThe role of endothelial mechanosensitive genes in atherosclerosis and omics approaches.Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airwaysFlow-mediated signaling modulates endothelial cell phenotype.The role of shear stress on ET-1, KLF2, and NOS-3 expression in the developing cardiovascular system of chicken embryos in a venous ligation model.Intimal hyperplasia: slow but deadly.Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions.Selective class IIa HDAC inhibitors: myth or reality.Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.Omics-based approaches to understand mechanosensitive endothelial biology and atherosclerosis.Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathwaysDisturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation.
P2860
Q24612560-B587AC4C-502C-48F9-973B-47B1853B02AEQ24653621-84B1C3F3-FFC3-41CC-9176-1C5B3F720AA5Q28115981-294F869A-8806-4D49-BD02-C51CF7266667Q28397740-6B27C28A-6BB5-40BD-BF51-9B35EC68FF38Q28553412-CDFB5C9E-6DD9-4F79-8C51-D8958CAEF19EQ28593879-0BEAC3F7-8BA2-4184-9724-61725232BB5FQ30497896-F783AC2C-B75C-429D-8F4C-E6D51384331CQ33426080-F5110FF2-B2B8-4A8C-A51D-8372ED727E29Q33613299-2A5D7096-4099-4DFC-8EAB-1E359F7F80E6Q33787467-6014ACEE-3B4F-4086-B40B-BBC46E81C865Q33788731-CE0D5F22-C5D9-42B1-8DA2-D81E63740F23Q33911239-D202609B-97AD-4C76-BDAE-798F86B1CE37Q34195975-9F0F9D48-C7E5-4A03-9A07-EB2DD8DD29B5Q34310249-6F7865A6-046C-4BB6-94DA-E8F63C781A29Q34597924-EC8151FD-644C-4A52-8DDB-0A90ED030E59Q34662020-CABE0F26-9CD6-41FF-9095-7A9E9E60A089Q34736483-97FE63A3-803B-4826-AC2F-15C693D4AD3DQ34787891-AB348032-0F6F-4E59-AB34-FA87D2DEB41EQ35012110-ABF7B87D-DFDF-4F05-AA6B-B4D401991284Q35067429-618A471B-D017-4E8F-A1A1-C059C07C1DBCQ35120893-F1F2B084-058C-4148-82C6-57B77BA8C057Q35128304-7006CF59-7C6C-4472-B6B7-C8ACD7CB1ED3Q35130262-364F72DB-F7D8-4231-B686-3F60E7304F47Q35900352-BEB55DB3-8E55-4C0E-A035-EC7C3F002F2CQ35906034-821497DE-32B0-4CA2-A206-2CE9F2B48C01Q36005139-347E4AFB-B294-4EDD-BA50-59F7490EA31BQ36337932-2CF54F25-985B-4577-8E1C-81B06A1D6B02Q36355647-77CF29B5-DCED-4C97-AC08-609631E2D66AQ36563042-EF414C06-5235-4358-B553-4EF32E7FCFF9Q36675994-C56A2121-0C8D-4C6A-86F5-96A56D9F4DC7Q36684465-2864DA1C-A917-4BA0-BBC9-C5C72F434A35Q37029658-0C892AE0-029A-46F9-A80A-F70545598294Q38023144-C676664E-EDB6-4D24-BBB6-CB4711DAD284Q38196790-287F518A-8530-4980-98A8-1BB7F11C6C2AQ38246144-002830AA-62BC-47FF-B5AA-545ECBE271C0Q38774316-269C92C6-C8C1-4382-9E25-BBEA9D10AD92Q38876119-F764C3D3-C777-4A2B-8F96-84FBD9CEA51BQ38883236-65298884-1785-4E7E-BA94-A26F4255806EQ38926909-3B8D0883-F4C6-4F0F-BF28-DFBC29CA545AQ39180450-F41BE84C-1F23-4DE4-A6AF-FB696F2B73AC
P2860
Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@en
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@nl
type
label
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@en
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@nl
prefLabel
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@en
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@nl
P2093
P2860
P1476
Tumor necrosis factor alpha-me ...... ppaB and histone deacetylases.
@en
P2093
Ajay Kumar
Mukesh K Jain
Sucharita SenBanerjee
Zhiyong Lin
P2860
P304
P356
10.1128/MCB.25.14.5893-5903.2005
P407
P577
2005-07-01T00:00:00Z